For the 150-mg armodafinil group versus placebo , there was a significantly greater decrease in least squares mean ( standard error of mean [ SEM ] ) IDS-C30 total score at week 8 ( -21.7 [ 1.1 ] vs -17.9 [ 1.1 ] ; P = .0097 ; Cohen d therapeutic effect size = 0.28 ) .